|1.||Phillips, Katharine A: 66 articles (07/2015 - 03/2002)|
|2.||Wilhelm, Sabine: 30 articles (09/2015 - 01/2002)|
|3.||Menard, William: 29 articles (10/2013 - 03/2005)|
|4.||Veale, David: 20 articles (12/2015 - 06/2003)|
|5.||Buhlmann, Ulrike: 20 articles (08/2015 - 01/2002)|
|6.||Didie, Elizabeth R: 15 articles (06/2014 - 02/2003)|
|7.||Feusner, Jamie D: 13 articles (09/2015 - 12/2007)|
|8.||Castle, David J: 12 articles (10/2015 - 09/2003)|
|9.||Fay, Christina: 12 articles (10/2006 - 03/2005)|
|10.||Phillips, K A: 11 articles (05/2013 - 01/2000)|
|1.||Body Dysmorphic Disorders (Body Dysmorphic Disorder)
03/01/2008 - "Although cognitive behavior therapy has been found to be very effective in the treatment of body dysmorphic disorder (BDD), there still remain a number of challenges that clinicians face in the treatment of individuals with BDD. "
01/01/2014 - "Cognitive-behavioural therapy (CBT) is an effective treatment for body dysmorphic disorder (BDD). "
01/01/2011 - "SRI is effective for patients with body dysmorphic disorder (BDD) in preoccupation with body appearance or sensation subgroup. "
11/01/2015 - "There is some evidence for the efficacy of cognitive behavior therapy (CBT) for body dysmorphic disorder (BDD) after 1 to 6months but none in the long term. "
01/01/2014 - "The evidence base for the efficacy of cognitive behaviour therapy (CBT) for treating body dysmorphic disorder (BDD) is weak. "
08/01/2014 - "We aimed to generate reference values for a healthy population and for a population of patients fulfilling diagnostic criteria for at least one of BDD, hypochondriasis, and CFS, treated in specialized mental health care. "
06/01/2010 - "This article provides a focused review of issues pertaining to BDD that are relevant to DSM-V. The review presents a number of options and preliminary recommendations to be considered for DSM-V: (1) Criterion A may benefit from some rewording, without changing its focus or meaning; (2) There are both advantages and disadvantages to adding a new criterion to reflect compulsive BDD behaviors; this possible addition requires further consideration; (3) A clinical significance criterion seems necessary for BDD to differentiate it from normal appearance concerns; (4) BDD and eating disorders have some overlapping features and need to be differentiated; some minor changes to DSM-IV's criterion C are suggested; (5) BDD should not be broadened to include body integrity identity disorder (apotemnophilia) or olfactory reference syndrome; (6) There is no compelling evidence for including diagnostic features or subtypes that are specific to gender-related, age-related, or cultural manifestations of BDD; (7) Adding muscle dysmorphia as a specifier may have clinical utility; and (8) The ICD-10 criteria for hypochondriacal disorder are not suitable for BDD, and there is no empirical evidence that BDD and hypochondriasis are the same disorder. "
01/01/2006 - "Current practice in DSM-IV is to classify OCD, BDD or hypochondriasis and a delusional disorder as separate entities; this way of classifying seems to be an artefact. "
01/01/2006 - "For instance, OCD, hypochondriasis, BDD and to a lesser degree anorexia nervosa can all be particularized as 'with good insight', 'with poor insight' or 'with psychotic features'. "
06/01/1995 - "Future research may indicate that obsessional disorders such as BDD, anorexia, OCD, and hypochondriasis, as well as other disorders such as major depression, should have qualifiers or subtypes--for example, "with good insight," "with poor insight," and "with delusional (or psychotic) thinking"--with an implied continuum of insight embraced by a single disorder. "
|3.||Paranoid Schizophrenia (Delusional Disorder)
01/01/2013 - "A considerable overlap exists between BDD and other psychiatric disorders such as OCD, anxiety, and delusional disorder, and this comorbidity should be considered in evaluation, management, and long-term follow-up of the disorder. "
10/01/2006 - "The difficulty to draw a discrete boundary between BDD and a delusional disorder of somatic type is highlighted."
04/01/1998 - "These data further suggest that the delusional variant of BDD (delusional disorder, somatic type) may also respond to SRIs. "
06/01/1995 - "The double coding allowed for BDD acknowledges that BDD and its delusional disorder variant may constitute a single disorder; that allowed for OCD acknowledges that OCD may be delusional. "
01/01/1994 - "Thus, BDD may have a psychotic subtype that significantly overlaps with, and may even be the same disorder as, its delusional disorder variant. "
|4.||Chronic Hepatitis (Chronic Active Hepatitis)
01/01/1990 - "Dimethyl-4, 4'-dimethoxy-5, 6, 5', 6'-dimethylenedioxy-biphenyl-2, 2'-dicarboxylate (biphenyldimethyldicarboxylate; BDD), a synthetic compound, has been used in the treatment of chronic hepatitis with good results in reducing s-GPT. "
04/01/1989 - "[Clinical effect of biphenyl dimethyl dicarboxylate administration on chronic hepatitis]."
11/01/2012 - "Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis."
05/01/2006 - "Biphenyl dimethyl dicarboxylate (DDB) is a hepatoprotectant, which is used as an adjuvant agent in a treatment for chronic hepatitis. "
06/01/1987 - "The therapeutic effect of biphenyl-dimethyl-dicarboxylate (DDB) on certain abnormal laboratory parameters in chronic hepatitis."
|5.||Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
09/01/2011 - "Therefore, in the present study we investigated whether individuals with BDD (n = 20) demonstrate impairments in reality monitoring relative to individuals with obsessive-compulsive disorder (OCD; n = 20) and healthy controls (n = 20). "
03/01/2004 - "In this study, we investigated (1) the ability to identify facial expressions of emotion, and (2) to discriminate single facial features in BDD patients, Obsessive-Compulsive Disorder (OCD) patients, and in healthy control participants. "
10/01/2015 - "Participants were 21 BDD patients, 19 obsessive-compulsive disorder (OCD) patients and 21 healthy controls (HC), who were age-, sex-, and IQ-matched. "
08/30/2015 - "Twenty-one BDD participants were compared with 19 obsessive-compulsive disorder (OCD) participants and 21 healthy controls (HC), who were age-, sex-, and IQ-matched. "
07/30/2015 - "BDD was significantly associated with a substantially elevated rate of suicide attempts, major depression, and obsessive-compulsive disorder. "
|1.||Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)
|2.||7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)
|7.||Clavulanic Acid (Potassium Clavulanate)
|8.||Antidepressive Agents (Antidepressants)
|5.||Drug Therapy (Chemotherapy)